Pathways for aberrant angiogenesis in pancreatic cancer

被引：129

作者：

M Korc

机构：

[1] Div. of Endocrinol. Diabetes/Metab., Department of Medicine, University of California, Irvine

来源：

关键词：

Vascular Endothelial Growth Factor; Pancreatic Cancer; Hepatocyte Growth Factor; Pancreatic Cancer Cell; Pancreatic Cancer Cell Line;

D O I：

10.1186/1476-4598-2-8

中图分类号：

学科分类号：

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. Although the specific mechanisms that dictate its biological aggressiveness are not clearly established, it is characterized by a variety of molecular alterations as well as by the overexpression of mitogenic and angiogenic growth factors and their receptors. PDACs also express high levels of vascular endothelial growth factor (VEGF). Recent studies indicate that suppression of VEGF expression attenuates pancreatic cancer cell tumorigenicity in a nude mouse model, and that VEGF can exert direct mitogenic effects on some pancreatic cancer cells. These findings suggest that cancer cell derived VEGF promotes pancreatic cancer growth in vivo via a paracrine angiogenic pathway and an autocrine mitogenic pathway, and provide novel opportunities for therapeutic intervention in this deadly disease. © 2003 Korc; licensee BioMed Central Ltd.

引用

页数：8

共 145 条

[71]

Udagawa T., Persistence of microscopic human cancers in mice: Alterations in the angiogenic balance accompanies loss of tumor dormancy, Faseb J., 16, 11, pp. 1361-1370, (2002)

[72]

Folkman J., What is the evidence that tumors are angiogenesis dependent?, J. Natl. Cancer Inst., 82, 1, pp. 4-6, (1990)

[73]

Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1, 1, pp. 27-31, (1995)

[74]

Santin A.D., Secretion of vascular endothelial growth factor in ovarian cancer, Eur. J. Gynaecol. Oncol., 20, 3, pp. 177-181, (1999)

[75]

Plate K.H., Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo, Nature, 359, 6398, pp. 845-848, (1992)

[76]

Goldman C.K., Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression, Neurosurgery, 40, 6, pp. 1269-1277, (1997)

[77]

Okada F., Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells, Proc. Natl. Acad. Sci. U. S. A., 95, 7, pp. 3609-3614, (1998)

[78]

Meadows K.N., Bryant P., Pumiglia K., Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation, J. Biol. Chem., 276, 52, pp. 49289-49298, (2001)

[79]

Blancher C., Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway, Cancer Res., 61, 19, pp. 7349-7355, (2001)

[80]

Yu J.L., Effect of p53 status on tumor response to antiangiogenic therapy, Science, 295, 5559, pp. 1526-1528, (2002)

← 3 4 5 6 7 8 9 10 11 12 →